189 related articles for article (PubMed ID: 22253721)
1. Genome-wide high-resolution aCGH analysis of gestational choriocarcinomas.
Poaty H; Coullin P; Peko JF; Dessen P; Diatta AL; Valent A; Leguern E; Prévot S; Gombé-Mbalawa C; Candelier JJ; Picard JY; Bernheim A
PLoS One; 2012; 7(1):e29426. PubMed ID: 22253721
[TBL] [Abstract][Full Text] [Related]
2. [Cytogenomic studies of hydatiform moles and gestational choriocarcinoma].
Poaty H; Coullin P; Leguern E; Dessen P; Valent A; Afoutou JM; Peko JF; Candelier JJ; Gombé-Mbalawa C; Picard JY; Bernheim A
Bull Cancer; 2012 Sep; 99(9):827-43. PubMed ID: 22877883
[TBL] [Abstract][Full Text] [Related]
3. Detection of non-maternal components of gestational choriocarcinoma by PCR-based microsatellite DNA assay.
Cankovic M; Gaba AR; Meier F; Kim W; Zarbo RJ
Gynecol Oncol; 2006 Nov; 103(2):614-7. PubMed ID: 16740299
[TBL] [Abstract][Full Text] [Related]
4. Genomic profile in gestational and non-gestational choriocarcinomas.
Mello JB; Ramos Cirilo PD; Michelin OC; Custódio Domingues MA; Cunha Rudge MV; Rogatto SR; Maestá I
Placenta; 2017 Feb; 50():8-15. PubMed ID: 28161066
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence In Situ Hybridization for the X and Y Chromosome Centromeres Helps Differentiate Between Gestational and Nongestational Choriocarcinoma in Clinically Ambiguous Cases.
Whaley RD; Dougherty RE; Cheng L; Ulbright TM
Arch Pathol Lab Med; 2020 Jul; 144(7):863-868. PubMed ID: 31846368
[TBL] [Abstract][Full Text] [Related]
6. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
[TBL] [Abstract][Full Text] [Related]
7. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series.
Zhang X; Yan K; Chen J; Xie X
Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690
[TBL] [Abstract][Full Text] [Related]
8. Cytogenomics of six human trophoblastic cell lines.
Weber M; Weise A; Vasheghani F; Göhner C; Fitzgerald JS; Liehr T; Markert UR
Placenta; 2021 Jan; 103():72-75. PubMed ID: 33096371
[TBL] [Abstract][Full Text] [Related]
9. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
10. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
[TBL] [Abstract][Full Text] [Related]
11. [Genetic genesis of choriocarcinoma].
Zhao J; Xiang Y; Wan XR; Feng FZ; Cui QC; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):35-40. PubMed ID: 20367924
[TBL] [Abstract][Full Text] [Related]
12. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line.
Nickel BE; Cattini PA
Endocrinology; 1991 May; 128(5):2353-9. PubMed ID: 1708334
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.
Huebner H; Strick R; Wachter DL; Kehl S; Strissel PL; Schneider-Stock R; Hartner A; Rascher W; Horn LC; Beckmann MW; Ruebner M; Fahlbusch FB
J Exp Clin Cancer Res; 2017 Nov; 36(1):165. PubMed ID: 29169400
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal abnormalities in choriocarcinomas of the female.
Rodriguez E; Melamed J; Reuter V; Chaganti RS
Cancer Genet Cytogenet; 1995 Mar; 80(1):9-12. PubMed ID: 7697645
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma.
Ahmed MN; Kim K; Haddad B; Berchuck A; Qumsiyeh MB
Cancer Genet Cytogenet; 2000 Jan; 116(1):10-5. PubMed ID: 10616525
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
Pang RT; Leung CO; Lee CL; Lam KK; Ye TM; Chiu PC; Yeung WS
BMC Cancer; 2013 Jan; 13():25. PubMed ID: 23327670
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.
Chao A; Tsai CL; Wei PC; Hsueh S; Chao AS; Wang CJ; Tsai CN; Lee YS; Wang TH; Lai CH
Cancer Lett; 2010 May; 291(1):99-107. PubMed ID: 19900756
[TBL] [Abstract][Full Text] [Related]
19. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines.
Sheppard DM; Fisher RA; Lawler SD
Cancer Genet Cytogenet; 1985 Apr; 16(3):251-8. PubMed ID: 4038916
[TBL] [Abstract][Full Text] [Related]
20. Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.
Fong PY; Xue WC; Ngan HY; Chiu PM; Chan KY; Tsao SW; Cheung AN
J Clin Pathol; 2006 Feb; 59(2):179-83. PubMed ID: 16443735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
